07 Jul 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/bionxts-sublingual-cladribine-program-for-ms-ready-for-next-phase-1046096
30 Aug 2024
// BUSINESSWIRE
17 Jul 2024
// ACCESSWIRE
25 Apr 2024
// ACCESSWIRE
https://www.accesswire.com/856964/bionxt-solutions-announces-odf-cladribine-update-and-financing
18 Mar 2024
// ACCESSWIRE
https://www.accesswire.com/843970/bionxt-reports-commercialization-of-odf-cladribine-product-for-ms-next-steps
10 Oct 2023
// BUSINESSWIRE